Immtech Pharmaceutical, Inc. is a biopharmaceutical company, located in Vernon Hills, Illinois, committed to the discovery and commercialization of treatments of infectious diseases in the developing as well as the developed world and to extending its medicinal chemistry platform to the treatment of cancer, metabolic diseases, and neurological disorders.
The company has successfully leveraged the research of a Consortium of well-known academic scientists by way of a license agreement, which gives Immtech exclusive, worldwide rights to compounds and discoveries made by the Research Consortium.
Immtech’s platform is based on cationic chemistry and includes nearly 3,000 compounds, which have been derived by directed medicinal chemical synthesis by its academic collaborators. Immtech has filed over 65 patents in the U.S. and over 200 patents worldwide covering composition of matter and use of the compounds. The patent estate includes approaches to producing the compounds as prodrugs, which make the cationic molecules orally bioavailable.
